Pfizer reports 1st quarterly loss since 2019 on weak COVID product… Pfizer on Tuesday urged investors to focus on growth in its non-COVID products… Read More...
Pfizer sees promising results from antibiotic combo for superbug… Descrease article font size Increase article… Read More...
Pfizer CEO says 2023 will be ‘transition year’ as it sees drop in… Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its… Read More...
Pfizer to seek U.S. approval for 2nd COVID booster for people 65 and… Pfizer Inc and its German partner BioNTech SE will seek emergency use… Read More...
Pfizer expects $29B in COVID-19 vaccine sales next year –… Pfizer Inc on Tuesday forecast better-than-expected $29 billion in sales… Read More...
